September 20, 2014 9:55 PM ET

Pharmaceuticals

Company Overview of Kémia, Inc.

Executive Profile

AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 0 different industries.

----

Background

Dr. Julius Rebek, Ph.D. co-founded Kémia, Inc., in 2002 and served as its Scientific Advisor. Dr. Rebek is a co-founder of several biotechnology companies, including Cubist Pharmaceuticals. Dr. Rebek is Director of The Skaggs Institute for Chemical Biology and a Professor of Chemistry at The Scripps Research Institute in San Diego. His other scientific achievements are development of the “three-phase test” for reactive intermediates and cleft-like structures for studies ...

Corporate Headquarters

5871 Oberlin Drive
San Diego, California 92121

United States

Phone: 858-964-1414
Fax: 858-964-1413

Board Members Memberships

There is no Board Members Memberships data available.

Education

Unknown/Other Education
Massachusetts Institute of Technology
PhD
Massachusetts Institute of Technology
Bachelor's Degree
University of Kansas

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Kémia, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.